Related Experiment Video
Updated: Mar 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition
Yuna Roh1,2, Jinhyeon Choi1,3, Jin-Seong Hwang1
1Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
G-protein-coupled receptor 161 (GPR161) drives melanoma progression by activating signal transducer and activator of transcription 3 (STAT3) and suppressing thioredoxin-interacting protein (TXNIP), promoting cell growth and metabolic reprogramming. GPR161 is a potential therapeutic target for melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Melanoma progression involves oncogenic signaling and metabolic reprogramming.
- The role of G-protein-coupled receptors (GPCRs) in these processes is not well understood.
Purpose of the Study:
- To investigate the role of GPR161 in melanoma progression.
- To elucidate the regulatory mechanisms and downstream effects of GPR161 in melanoma.
Main Methods:
- Promoter analysis and ChIP-qPCR to assess STAT3 binding to GPR161.
- Functional studies involving GPR161 and STAT3 inhibition/silencing.
- Transcriptomic profiling to identify downstream targets.
- Analysis of Cancer Genome Atlas datasets.
Main Results:
- GPR161 is upregulated in melanoma and associated with poor survival.
- GPR161 promotes melanoma cell proliferation and migration.
- STAT3 directly activates GPR161 transcription, promoting melanoma growth.
- GPR161 negatively regulates TXNIP, enhancing glycolytic capacity and proliferation.
- A STAT3-GPR161-TXNIP axis was identified, with low TXNIP predicting poor survival.
Conclusions:
- GPR161 promotes melanoma malignancy by linking STAT3 activation to TXNIP suppression and metabolic enhancement.
- GPR161 represents a potential biomarker and therapeutic target for melanoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a...

